Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? [7] (multiple letters)

Basit Öğe Kaydı
dc.authorscopusid15620052500
dc.authorscopusid7005611167
dc.authorscopusid7004350085
dc.authorscopusid7006724146
dc.authorscopusid7006788475
dc.authorscopusid7004329495
dc.authorscopusid36447799500
dc.contributor.authorFournier A.
dc.contributor.authorGodefroy O.
dc.contributor.authorOprisiu R.
dc.contributor.authorSlama M.
dc.contributor.authorAndrejak M.
dc.contributor.authorMacWalter R.S.
dc.contributor.authorWong K.Y.K.
dc.date.accessioned2024-08-04T19:59:13Z
dc.date.available2024-08-04T19:59:13Z
dc.date.issued2003
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1161/01.STR.0000044950.15362.A4
dc.identifier.endpage9en_US
dc.identifier.issn0039-2499
dc.identifier.issue1en_US
dc.identifier.pmid12511742en_US
dc.identifier.scopus2-s2.0-0037226842en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage8en_US
dc.identifier.urihttps://doi.org/10.1161/01.STR.0000044950.15362.A4
dc.identifier.urihttps://hdl.handle.net/11616/90470
dc.identifier.volume34en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofStrokeen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectangiotensin 1 receptor antagonisten_US
dc.subjectatenololen_US
dc.subjectcaptoprilen_US
dc.subjectdipeptidyl carboxypeptidase inhibitoren_US
dc.subjectindapamideen_US
dc.subjectlosartanen_US
dc.subjectperindoprilen_US
dc.subjectthiazide diuretic agenten_US
dc.subjectanamnesisen_US
dc.subjectcell protectionen_US
dc.subjectclinical trialen_US
dc.subjectcomorbidityen_US
dc.subjectdisease associationen_US
dc.subjectdisease courseen_US
dc.subjectdrug efficacyen_US
dc.subjecthumanen_US
dc.subjectkidney diseaseen_US
dc.subjectkidney functionen_US
dc.subjectletteren_US
dc.subjectmortalityen_US
dc.subjectpriority journalen_US
dc.subjectrecurrent diseaseen_US
dc.subjectrisk assessmenten_US
dc.subjectstrokeen_US
dc.subjectsudden deathen_US
dc.subjecttreatment outcomeen_US
dc.subjecttreatment planningen_US
dc.subjectAngiotensin-Converting Enzyme Inhibitorsen_US
dc.subjectAntihypertensive Agentsen_US
dc.subjectCerebrovascular Accidenten_US
dc.subjectClinical Trialsen_US
dc.subjectHumansen_US
dc.subjectIndapamideen_US
dc.subjectKidney Diseasesen_US
dc.subjectPerindoprilen_US
dc.subjectRamiprilen_US
dc.subjectReceptor, Angiotensin, Type 1en_US
dc.subjectReceptors, Angiotensinen_US
dc.titleConverting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction? [7] (multiple letters)en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu